Bioventus (BVS) Gross Margin (2020 - 2026)

Bioventus' Gross Margin history runs 7 years deep, the most recent figure standing at 68.72% for Q1 2026.

• Quarterly Gross Margin rose 167.0% year-over-year to 68.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 68.69% (up 124.0% YoY) and the FY2025 annual result came in at 68.33%, up 61.0% from the prior year.
• Gross Margin was 68.72% for Q1 2026 at Bioventus, roughly flat from 68.89% in the prior quarter.
• Across five years, Gross Margin topped out at 69.14% in Q2 2025 and bottomed at 58.96% in Q4 2022.
• A 5-year average of 66.29% and a median of 67.05% in 2025 frame the typical range for Gross Margin.
• Annual changes were most pronounced in 2022 — Gross Margin sank 834 bps — and 2024, when it soared 618 bps.
• Bioventus' Gross Margin stood at 58.96% in 2022, then climbed by 8 bps to 63.73% in 2023, then advanced by 5 bps to 66.82% in 2024, then rose by 3 bps to 68.89% in 2025, then declined by 0 bps to 68.72% in 2026.
• Business Quant data shows BVS's Gross Margin at 68.72% in Q1 2026, 68.89% in Q4 2025, and 67.96% in Q3 2025.